Category Archives: Guest Blog

Making the Most of Social Media (Within FDA’s New Guidelines)

By Ken Ribotsky. Pharmaceutical companies have begun using social media for business needs and promotion, yet have been hesitant to become too engaged since the FDA’s stance on social media activity remained unclear. But now that we know the FDA’s specific guidelines for pharma companies’ actions online, it’s time for brands to consider diving into […]
Also posted in compliance, E-Media, FDA, Op-Ed, Regulatory, social media | Tagged , | 1 Comment

Key Clinical Trial Themes from DIA 2014

The Drug Information Association (DIA), one of the largest non-profit organizations supporting clinical research and drug development, held its 2014 annual meeting in San Diego last week. Applied Clinical Trials’ Moe Alsumidaie looks at three of the key themes from this year’s meeting: incorporating advocacy groups and patient voices in clinical research, breakthrough research applications, and […]
Also posted in Events, Global, Meetings, R&D, Technology | Tagged , , , , , | Leave a comment

The Rx Firm Tax Exodus: Is Something Wrong with the U.S. System?

As I read the latest reports of yet another big US Rx firm, this time AbbVie, trying to pull off a “tax inversion” takeover of the Irish-based Shire, I couldn’t help but wonder, what the heck is going on here? Right now, it feels like most major US corporations, especially pharmas, are literally running away […]
Also posted in Deals, Europe, Global, Legal, Op-Ed, Strategy | Tagged , , , , , , | Leave a comment

Some Content on Content Marketing

by Al Topin Do I have the only e-mail inbox clogged with more and more content about content marketing? You know, content marketing agencies or software vendors sending content about how you, too can learn to do content marketing? Add this to what I get from brands doing content marketing, and my inbox seems like […]
Also posted in Advertising, Agency Insight, leadership, Marketing | Tagged , | Leave a comment

New Social Media Guidelines: What FDA Says, and What It Means

By Simon Beins is Associate Director, Strategy, Heartbeat Ideas & Heartbeat West. Earlier this year, FDA promised three sets of guidelines to clarify using social media for pharma marketing. Last week it delivered two of them The first, Internet/Social Media Platforms with Character Space Limitation—Presenting Risk and Benefit Information for Prescription Drugs and Medical Devices, […]
Also posted in E-Media, FDA, multimedia, Regulatory, social media | Tagged , , , , | Leave a comment
  • Categories

  • Meta